291 related articles for article (PubMed ID: 15491686)
21. [Surgical treatment of radiogenic prostate-urethra-rectum fistula].
Lang W; Meister R
Chirurg; 1990 Apr; 61(4):312-5. PubMed ID: 2347267
[TBL] [Abstract][Full Text] [Related]
22. Prostate high-dose-rate brachytherapy as salvage treatment of local failure after previous external or permanent seed irradiation for prostate cancer.
Tharp M; Hardacre M; Bennett R; Jones WT; Stuhldreher D; Vaught J
Brachytherapy; 2008; 7(3):231-6. PubMed ID: 18579446
[TBL] [Abstract][Full Text] [Related]
23. Undetectable prostate specific antigen at 6-12 months: a new marker for early success in hormonally treated patients after prostate brachytherapy.
Miller N; Smolkin ME; Bissonette E; Theodorescu D
Cancer; 2005 Jun; 103(12):2499-506. PubMed ID: 15852361
[TBL] [Abstract][Full Text] [Related]
24. Combination external beam radiation and brachytherapy boost with androgen suppression for treatment of intermediate-risk prostate cancer: an initial report of CALGB 99809.
Hurwitz MD; Halabi S; Ou SS; McGinnis LS; Keuttel MR; Dibiase SJ; Small EJ
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):814-9. PubMed ID: 18407435
[TBL] [Abstract][Full Text] [Related]
25. Reconstruction of radiation-induced injuries of the lower urinary tract.
Ballek NK; Gonzalez CM
Urol Clin North Am; 2013 Aug; 40(3):407-19. PubMed ID: 23905939
[TBL] [Abstract][Full Text] [Related]
26. Prostate cancer: 7. Radiation therapy for localized disease.
Warde P; Catton C; Gospodarowicz MK
CMAJ; 1998 Dec; 159(11):1381-8. PubMed ID: 9861209
[No Abstract] [Full Text] [Related]
27. Severity categories of the International Prostate Symptom Score before, and urinary morbidity after, permanent prostate brachytherapy.
Gutman S; Merrick GS; Butler WM; Wallner KE; Allen Z; Galbreath RW; Adamovich E
BJU Int; 2006 Jan; 97(1):62-8. PubMed ID: 16336330
[TBL] [Abstract][Full Text] [Related]
28. Combined brachytherapy with external beam radiotherapy for localized prostate cancer: reduced morbidity with an intraoperative brachytherapy planning technique and supplemental intensity-modulated radiation therapy.
Zelefsky MJ; Nedelka MA; Arican ZL; Yamada Y; Cohen GN; Shippy AM; Park JJ; Zaider M
Brachytherapy; 2008; 7(1):1-6. PubMed ID: 18299108
[TBL] [Abstract][Full Text] [Related]
29. (125)I monotherapy using D90 implant doses of 180 Gy or greater.
Kao J; Stone NN; Lavaf A; Dumane V; Cesaretti JA; Stock RG
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):96-101. PubMed ID: 17980505
[TBL] [Abstract][Full Text] [Related]
30. Factors associated with the frequency of self-intermittent catheterization after prostate brachytherapy.
Schwartz DJ; Schild SE; Wong WW; Vora SA
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):60-3. PubMed ID: 15629594
[TBL] [Abstract][Full Text] [Related]
31. Biochemical and functional outcomes following brachytherapy with or without supplemental therapies in men < or = 50 years of age with clinically organ-confined prostate cancer.
Merrick GS; Wallner KE; Galbreath RW; Butler WM; Brammer SG; Allen ZA; Lief JH; Adamovich E
Am J Clin Oncol; 2008 Dec; 31(6):539-44. PubMed ID: 19060584
[TBL] [Abstract][Full Text] [Related]
32. Only carefully selected patients may have a beneficial effect of salvage cryoablation in recurrent prostate cancer after radiotherapy.
Elkjær MC; Borre M
Dan Med J; 2013 Dec; 60(12):A4756. PubMed ID: 24355453
[TBL] [Abstract][Full Text] [Related]
33. [Brachytherapy in prostatic adenocarcinoma].
Haie-Meder C; Court B; Perrin JL; Wibault P; Lartigau E; Gerbaulet A
Ann Urol (Paris); 1994; 28(6-7):295-301. PubMed ID: 7893114
[TBL] [Abstract][Full Text] [Related]
34. Permanent interstitial brachytherapy in younger patients with clinically organ-confined prostate cancer.
Merrick GS; Butler WM; Wallner KE; Galbreath RW; Adamovich E
Urology; 2004 Oct; 64(4):754-9. PubMed ID: 15491715
[TBL] [Abstract][Full Text] [Related]
35. Salvage radiotherapy for men with isolated rising PSA or locally palpable recurrence after radical prostatectomy: do outcomes differ?
MacDonald OK; Schild SE; Vora S; Andrews PE; Ferrigni RG; Novicki DE; Swanson SK; Wong WW
Urology; 2004 Oct; 64(4):760-4. PubMed ID: 15491716
[TBL] [Abstract][Full Text] [Related]
36. [Prostate cancer brachytherapy].
Pommier P; Guérif S; Peiffert D; Créhange G; Hannoun-Lévi JM; de Crevoisier R
Cancer Radiother; 2016 Sep; 20 Suppl():S210-5. PubMed ID: 27523412
[TBL] [Abstract][Full Text] [Related]
37. Prostate-specific antigen relapse-free survival in patients with localized prostate cancer treated by brachytherapy.
Joseph J; Al-Qaisieh B; Ash D; Bottomley D; Carey B
BJU Int; 2004 Dec; 94(9):1235-8. PubMed ID: 15610096
[TBL] [Abstract][Full Text] [Related]
38. Correlation between dosimetric parameters and late rectal and urinary toxicities in patients treated with high-dose-rate brachytherapy used as monotherapy for prostate cancer.
Konishi K; Yoshioka Y; Isohashi F; Sumida I; Kawaguchi Y; Kotsuma T; Adachi K; Morimoto M; Fukuda S; Inoue T
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1003-7. PubMed ID: 19345517
[TBL] [Abstract][Full Text] [Related]
39. High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy's 10-year results.
Demanes DJ; Rodriguez RR; Schour L; Brandt D; Altieri G
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1306-16. PubMed ID: 15817332
[TBL] [Abstract][Full Text] [Related]
40. Does transurethral resection of prostate (TURP) affect outcome in patients who subsequently develop prostate cancer?
D'Ambrosio DJ; Ruth K; Horwitz EM; Chen DY; Pollack A; Buyyounouski MK
Urology; 2008 May; 71(5):938-41. PubMed ID: 18279939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
